Background and Purpose-Dietary sodium reduction with concurrent increase in potassium intake is a current public health priority to reduce risk of cardiovascular events. This study explored associations between the spot urine sodiumto-potassium ratio and cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis) longitudinal cohort. Methods-The MESA is a prospective cohort study of 6814 adults from 4 ethnic groups (European-, Asian-, African-and Hispanic-American) with a mean age of 62 (±10.2) years and an average of 11.7 (±2.2) years of follow-up. Participants were free of clinical cardiovascular disease at baseline. Spot urine sodium and potassium excretion, as a marker of dietary intake, was collected at baseline. The impact of urinary sodium-to-potassium ratio on adjudicated cardiovascular events was assessed using Cox proportional hazards models. Results-Only 39% of MESA participants had a urinary sodium-to-potassium ratio ≤1, and these participants experienced only 74 of the 236 strokes. A sodium-to-potassium ratio >1 was associated with a hazard ratio of 1.47 (95% CI,1.07-2.00) for risk of stroke, adjusting for age, sex, race, cardiovascular risk factors, socio-demographic characteristics, body size, and kidney function. Conclusions-The spot urine sodium-to-potassium ratio (measurable in routine care) is associated with stroke. A urine sodium-to-potassium ratio of ≤1, may be related to a clinically relevant reduction in stroke risk and is a feasible target for health interventions. C ardiovascular disease is a leading cause of mortality, and hypertension is a known modifiable risk factor. 1 Dietary sodium reduction and a corresponding increase in potassium intake are the twin mainstays in nutrition guidance to reduce cardiovascular disease risk and control blood pressure. [2] [3] [4] [5] It is universally acknowledged that dietary sodium intakes at population level are too high and potassium levels too low. 6, 7 Studies based on the National Health and Nutrition Examination Survey (2011Survey ( -2012 reported that adults >20 years consumed a mean of 3592 mg/d sodium and 2793 mg/d potassium.
C ardiovascular disease is a leading cause of mortality, and hypertension is a known modifiable risk factor. 1 Dietary sodium reduction and a corresponding increase in potassium intake are the twin mainstays in nutrition guidance to reduce cardiovascular disease risk and control blood pressure. [2] [3] [4] [5] It is universally acknowledged that dietary sodium intakes at population level are too high and potassium levels too low. 6, 7 Studies based on the National Health and Nutrition Examination Survey (2011) (2012) reported that adults >20 years consumed a mean of 3592 mg/d sodium and 2793 mg/d potassium. 8 These consumption estimates for sodium were far above the national guidelines of 2300 to 2400 mg sodium/ person/day. [2] [3] [4] 9 In contrast, consumption estimates for potassium were far below the stated 4700 mg potassium/person/day goal. 9 Some reports show the consumption of sodium and potassium has remained stable over time, suggesting a continued need to address these dietary components. 7, 10 Most studies that assess sodium and potassium intake rely on self-reported dietary measures. Yet, these measures are subject to many limitations, including poor recall and inaccurate or incomplete databases. 11, 12 Urinary excretion of sodium and potassium are good estimates of dietary intake and are not subject to the aforementioned limitations. 11 Furthermore, using sodium-to-potassium ratios, instead of absolute thresholds, could be useful for formulating dietary guidelines to meet wide-ranging energy needs, as suggested by Drewnowski et al, 13 and the ratio may better reflect cardiovascular change to disease (CVD) risk. [14] [15] [16] A recent meta-analysis of observational studies does support a relationship between dietary sodium-topotassium ratio and risk of stroke. 17 The present study adds to the current body of literature by assessing the specific hypothesis that urinary sodium-to-potassium ratio, obtained from spot urines, would predict the risk of subsequent major CVD in a diverse and multiethnic American population.
Spot Urine Sodium-to-Potassium Ratio Is a Predictor of Stroke
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Methods
The data used for this project are available through the data coordinating center for the MESA (Multi-Ethnic Study of Atherosclerosis) project (https://www.uwchscc.org/ and https://www.mesa-nhlbi. org/). All data requests must be approved by the MESA publications and presentations committee because of concerns from NHLBI about identifiability of individual participants in the full MESA data set.
Sample
The MESA is a large prospective cohort of 6814 individuals recruited from 6 field centers (New York, NY; Baltimore, MD; Chicago, IL; Los Angeles, CA; Minneapolis-St. Paul, MN; and Winston-Salem, NC). At enrollment, participants were aged 45 to 84 years and were selected based on having no clinical CVD events or CVD procedures. By design, 4 racial/ethnic groups were represented in the selection of participants: European-American, black, Chinese-American, and Hispanic-American. The study includes 5 clinical exams to date, which were performed from July 2000 to January 2012. A more detailed description of the study design can be found elsewhere. 18 The study was conducted under the guidelines of the Declaration of Helsinki and approved by the institutional review boards at each site.
Written informed consent of all participants was obtained.
Procedure
Spot urine samples were collected from participants at the time of exam 1 (July 2000 to August 2002). Measures of sodium and potassium excretion were used as a short-term estimate of intake. The amount of sodium excreted in urine is nearly equivalent to intake of dietary sodium. 9 Researchers estimate that 77% to 90% of dietary potassium is excreted in the urine and urinary potassium is highly correlated with potassium intake. 9 The MESA collected a broad range of covariate data on study participants. MESA participants were asked to come to a morning clinic examination after an overnight fast and were given standard questionnaires to assess a variety of risk factors which included demographic information, smoking, and any medical history of either hypertension or diabetes mellitus at the time of the exam. Participants were asked to bring their medications to the clinic to permit a medication inventory, and diet was assessed using a food frequency questionnaire. Anthropometric measures and blood pressures were also taken on all study participants at each exam. The amount of physical activity was assessed via questionnaire.
Event Adjudication
MESA identifies possible myocardial infarction (MI), heart failure (HF), peripheral vascular disease (PVD), stroke, and other events using participant self-report (as part of a broader range of events that are ascertained as primary study end points) as its primary means of outcome detection. Participants may report these events at clinic visits, during follow-up telephone calls, or by directly contacting the MESA field center postevent. After each contact, the MESA staff member documents any possible events through both review and abstraction of medical records and death certificates, interviews, and such, to gather as much information as possible about the event. At least 2 MESA physicians review the case materials for each MI and stroke. Differences in diagnoses between 2 MESA physician reviewers are resolved by the committees involved. Mean follow-up time for events was over 11 years.
Statistical Analysis
MESA covariates of interest at baseline (2000) (2001) (2002) were examined using descriptive statistics, including an evaluation of sodium, potassium, and sodium-to-potassium ratio means/proportions by covariates. The primary covariates of interest included the diverse demographics of MESA, namely age, sex, and race/ethnicity.
We examined the associated between sodium-to-potassium ratio and adjudicated CVD using both a threshold for the sodium-to-potassium ratio of >1 and sodium-to-potassium ratio as a continuous variable. For outcomes, we considered CVD events (MI, definite angina, stroke, transient ischemic attack, coronary heart disease death), coronary heart disease (MI and angina), HF, 20 PVD, 20 and stroke. We considered 3 levels of adjustment. First, we adjusted for age, sex, and race. Then, for model 2 (our primary model), we also adjusted for diabetes mellitus, smoking (current and former), total cholesterol, HDL (high-density lipoprotein) cholesterol, and treated hypertension. For model 3, we added variables that could have been either confounders or mediators, namely: education, systolic blood pressure, diastolic blood pressure, urine creatinine, hip circumference, body mass index, aspirin use, intentional exercise, and glomerular filtration rate. Further adjustment was made for dietary energy intake, maximum of common carotid artery intimal medial thickness, and IL-6 (interleukin 6) levels. We excluded participants who Diabetes mellitus, n (%) 837 (12.5) eGFR indicates estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; and MESA, Multi-Ethnic Study of Atherosclerosis consumed <400 or >6000 calories per day, as determined by the food frequency questionnaire because those extremes are implausible estimates of participants' true energy intake. All associations were estimated by Cox proportional hazards models, with the proportionality of hazards assessed by graphical methods.
Statistical analysis was performed with Stata 11 (StataCorp LP) and SAS 9.1.4. Results were statistically significant at the level of P<0.05.
Results
The mean age of the 6705 MESA participants with complete data at baseline was 61.2 years (Table 1) , with 37% of participants already receiving antihypertensive therapy at baseline. The participants averaged a sodium-to-potassium ratio of 1.30 (Table 2) , although 39% of participants had a ratio of ≤1 (Table I in the online-only Data Supplement).
Higher levels of sodium in the spot urine had a cross-sectional association with higher systolic blood pressure, whereas the inverse was true with potassium. A higher sodium-topotassium ratio was, as expected, associated with a higher systolic blood pressure (Table 3 ).
Our primary model (model 2) showed an increase in risk for all CVD (MI, definite angina, stroke, transient ischemic attack, coronary heart disease death) with a hazard ratio (HR) of 1.25 (95% CI, 1.08-1.45 after adjustment; Table 4 ). Model 2 also showed an increase risk for stroke with a HR of 1.54 (95% CI, 1.17-2.05 after adjustment; Table 4 ). Associations with HF, all coronary heart disease events (CHD), and PVD did not achieve significance. Increasing the statistical adjustment to increase variables that are potential mediators of the association, like systolic and diastolic blood pressure, left only stroke as statistically significant at HR, 1.47 (95% CI, 1.07-2.00). The stroke association was not influenced by further adjustment for total energy intake, IL-6 levels, and carotid intima-media thickness (HR, 1.40; 95% CI, 1.02-1.94), done as a sensitivity analysis. Furthermore, we did not exclude individuals on diuretics in the primary analysis as shown in Table 4 . However, in follow-up test using our primary model (model 2) for stroke, excluding all participants taking diuretics (≈15% of the sample) resulted in a minimal shift in the primary estimate of the association, with an HR of 1.65 (1.16-2.33, P=0.0048).
We also considered sodium-to-potassium ratio as a continuous variable, to determine how the risk changes with lower ratios. The data for the sodium-to-potassium ratio is quite skewed (Figure 1) . Generalized additive models were used to assess the linearity of the sodium-to-potassium ratio and outcomes. We were not able to reject the null hypothesis of a linear relation between the sodium-to-potassium ratio and stroke (P=0.19), HF (P=0.58), PVD (P=0.23), and all CVD (P=0.63) in this data. We found an association with incident stroke events (HR, 1.17; 95% CI, 1.03-1.32), after full adjustment (Table 5 ) and when comparing lowest to the highest tertiles of the sodium-to-potassium ratio (HR, 1.50; 95% CI, 1.09-2.07; Table II in the online-only Data Supplement). Associations with HF, all CVD, all coronary heart disease events, and PVD did not achieve statistical significance. 
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A log transformation of the sodium-to-potassium ratio yielded consistent measures of association. We found an association between log transformed sodium-to-potassium ratio with all CVD events (HR, 1.13; 95% CI, 1.01-1.26) and stroke events (HR, 1.26; 95% CI, 1.03-1.55), after adjusting for our primary variables of interest (model 2). As before, associations with HF, coronary heart disease events, and PVD did not achieve statistical significance.
The sodium-to-potassium ratio of 1 was selected because it was both easy to interpret in a clinical setting and was significantly associated with stroke. However, we also looked at other ratios based on American Heart Association guidelines, which included a ratio of 0.49, representing the recommendations for the general public and a ratio of 0.32, which corresponds to recommendations made for individuals at high risk of hypertension. 2 We assessed these ratios using the model 2 adjustment covariates. Notably, few MESA participants met either of the American Heart Association ratios (Table  I in the online-only Data Supplement). Only 8 of the 236 strokes occurred among the 256 participants meeting the 0.32 sodium-to-potassium ratio threshold; thus, the HR estimate of 1.24 (95% CI, 0.61-2.52) is imprecise because of the small number of participants who managed to achieve this relatively extreme ratio. Similarly, there were only 25 strokes among the 664 participants meeting the threshold of 0.49, which yield an estimate of HR, 0.97 (95% CI, 0.64-1.48). Last, using values from the Lowess plot ( Figure I in the online-only Data Supplement) where the risk crosses the null yielded quite similar estimates to the ratio of 1, HR, 1.41 (95% CI, 1.08-1.84), suggesting that the proposed ratio of 1 cannot be greatly improved on by fitting the cut point to the observed data.
Discussion
Urinary sodium-to-potassium ratios of ≤1, as measured by spot urines in the MESA, were associated with a 40% to 50% lower risk of strokes. Should this association be causal, this is a clinically meaningful decrease in a common and crippling disease. There was also the expected association between low sodium-to-potassium ratios and lower baseline blood pressure. This evidence is consistent with other studies showing that the sodium-to-potassium ratio is associated with CVD. 21, 22 Furthermore, these associations were obtained in a multiethnic cohort of older adults, showing generalizability of these findings across populations with a concern for cardiovascular Model 2: Age, sex, race, diabetes mellitus, smoking (current and former), total cholesterol, HDL cholesterol, and treated hypertension. Model 3: Age, sex, race, diabetes mellitus, smoking (current and former), total cholesterol, HDL cholesterol, treated hypertension, education, systolic blood pressure, diastolic blood pressure, hip circumference, body mass index, aspirin use, intentional exercise, and GFR. CHD indicates coronary heart disease events; CVD, cardiovascular events; HDL, high-density lipoprotein; GFR, glomerular filtration rate; and PVD, peripheral vascular disease. *P<0.05. disease, and the spot urine biomarker is easy to measure in modern routine clinical care. Studies have only recently begun to explore the feasibility of meeting the longstanding guidelines to lower sodium and increase potassium intake by populations at risk of CVD events. 13, 15 Our data showing that 2.8% of at-risk individuals had urinary ratios of <0.32 (as entailed by the American Heart Association recommendations), suggests that some current guidelines are not really feasible for middle aged and older American adults (Table I in the online-only Data Supplement). Because the sodium and potassium guidelines for at-risk populations appear to be aspirational, we will benefit by identifying a ratio that is both feasible to achieve and clinically meaningful. We propose a ratio where ≤1.0 (on the mg/dL scale) serves as an attainable initial goal for achieving a balance of sodium and potassium in the diet and is close to the median for the population. It is important to note that we do not have data from this study suggesting that lower sodium-to-potassium ratio necessarily needs to be obtained through improved diet quality. However, studies suggest that diets high in fruits, vegetables, whole grains, fish, nuts, and dairy are most likely to improve cardiometabolic health and is the suggested strategy to achieve a lower sodium-to-potassium ratio. 23 Furthermore, a ratio of 1 is both easy to calculate and explain in a clinical setting. Our study found a ratio meets both the criteria of being achievable (39% of participants met this ratio at baseline) and clinically meaningful, because of the association with stroke, in a multiethnic older American adult cohort. The goal of a sodium-to-potassium ratio of <1.0 (on the mg/dL scale) seems to segment risk based on statistical models and the shape of the association ( Figure I in the online-only Data Supplement), making it a possible target for public and individual health efforts, as in a recent clinical trial. 24 Spot urines for sodium-to-potassium ratio have large utility in the clinical setting given to their ease of administration, low cost, and quick interpretation. Spot urine may have some errors because of recent intake, although we expect this type of nondifferential misclassification to dilute the strength of the association. To guard against such an issue, providers may discuss typical dietary patterns and perform follow-up measures to ensure that clinical care is not dictated by a single error-prone measure, as well as to measure progress in meeting dietary goals.
Because the American Heart Association guidelines are for much lower than a ratio of 1, a patient meeting a sodium-to-potassium ratio of ≤1 is moving towards the optimal level of intake. 2 Our goal is not to dispute the high-quality and evidence-based American Heart Association guidelines, so much as to suggest a feasible and clinically relevant intermediate goal on the pathway to improving public health.
Limitations
We used spot urine measures, which despite previous successful use 25 are not as ideal as 24-hour measures for determining the absolute levels of sodium and potassium. 26 We avoided inference on the association of spot urine measures of sodium and potassium on events (Table III in the online-only Data Supplement) because of worries about the raw measures (taking the ratio should be at least partially correct for concentration as both measures are simultaneously diluted). It is unclear to what degree potassium is directly causal and could be supplemented in the diet or if it is a marker of dietary patterns that may lower stroke risk. Participants in MESA are not routinely supplementing with potassium, and any use of potassium supplementation to increase the sodium-to-potassium ratio should await high-quality clinical trial evidence and not be based on these associations. Like all observational studies, there is the possibility of residual confounding. We adjusted for a broad range of covariates, including possible intermediate variables, like systolic blood pressure (Table 3) which was independently associated with the sodium-to-potassium ratio. However, possible additional unknown factors may exist. We did not correct for multiple testing between end points, but our stroke finding would be robust to adjustment using the false discovery rate. 27 The lack of attenuation for stroke risk across the models was surprising, along with the finding that the association was stronger for stroke than the with CVD, coronary heart disease events, HF, and PVD (Table 4) . It is interesting to speculate that the sodium-to-potassium ratio may be a marker of other risk factors of physiological processes not provided in the model. Furthermore, it is intriguing to consider how causal pathways differ across the cardiovascular disease assessed in this article and how that may impact the different associations seen between the sodium-to-potassium ratio and cardiovascular outcomes. Similarly, there is limited ability to be certain about the causal role of sodium, despite decades of high-quality research, as some of the association attributed to sodium levels may still be acting as marker for diet quality. Future studies could explore whether the Model 2: Age, sex, race, diabetes mellitus, smoking (current and former), total cholesterol, HDL cholesterol, and treated hypertension. Model 3: Age, sex, race, diabetes mellitus, smoking (current and former), total cholesterol, HDL cholesterol, treated hypertension, education, systolic blood pressure, diastolic blood pressure, urine creatinine, hip circumference, body mass index, aspirin use, intentional exercise, and GFR. CHD indicates coronary heart disease events; CVD, cardiovascular events; HDL, high-density lipoprotein; GFR, glomerular filtration rate; and PVD, peripheral vascular disease. *P<0.05.
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sodium-potassium ratio is a mediator of disease or a marker of other biological or behavioral factors.
Conclusions
We demonstrate that a sodium-to-potassium ratio over 1, collected from spot urines, is associated with a greater risk of stroke over eleven years of follow-up in adult Americans of diverse race/ethnicity. It may also, potentially, be associated with a broader range of CVD. The collection of spot urines is part of routine clinical care, and the measurement of these biomarkers is inexpensive, suggesting strong potential to use spot urines ratios in clinical care settings. Furthermore, an intermediate target (sodium-to-potassium ratio's <1) is attractive for future public health interventions, and our data continues to provide evidence that sodium and potassium are linked to cardiovascular health.
